Emerging Biologics in Therapeutics

The main theme of this track is to have sound knowledge in the emerging biosimilar products like Recombinant blood products, therapeutic proteins, vaccines, Growth hormones, Biosimilar peptides, therapeutic proteins, biosimilar antibodies.Biosimilar insulins are the most expected ones in the class to enter the biosimilar landscape as patents for major branded insulin products start to expire in the next few years.

The proportion of orphan to non-orphan biologics receiving approvals in the 80s were around 140 which saw a growth in the 90s to 170. However, till the early next decade it experienced a fall to 140 again. From the late 90s to 2009 the graph attained a growth phase of gradually rising to 170 approvals and continuing to over 220 approvals till the end last of last decade.

Biosimilar insulins are the most expected ones in the class to enter the biosimilar landscape as patents for major branded insulin products start to expire in the next few years. The main theme of this track is to have sound knowledge in the emerging biosimilar products like Recombinant blood products, therapeutic proteins, vaccines, Growth hormones, Biosimilar peptides, therapeutic proteins, biosimilar antibodie. The emerging biosimilars are most likely to take the major share of the market in the ensuing approaches for line of treatments of different diseases and disorders.

 

  • Biologics in diabetes
  • Biologics in autoimmune disease
  • Biologics in cardivascular diseases
  • Biologics in digestive disorders
  • Biologics in genetic disorders
  • Biologics in neurologic disorders
  • Biologics in respiratory disorders
  • Biologics for Psoriasis
  • Biologics In Cancer

Related Conference of Emerging Biologics in Therapeutics

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Emerging Biologics in Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in